Skip to content

Released Apr 30, 2018, after the close

10-Q filed Apr 30, 2018, 30 days after period end · 0001564590-18-009864

Q1 2018 · 10-Q
Revenue$108.71M+5.8% vs Q1 2017−7.0% vs Q4 2017
Net Income$5.23MN/M vs Q1 2017+233.3% vs Q4 2017
EPS Diluted$0.27N/M vs Q1 2017+237.5% vs Q4 2017
Gross Profit$84,562,000+5.5%
Operating Income$7,870,000+33.0%
Operating Cash Flow-$3,560,000N/M
Free Cash Flowderived-$6,391,000N/M
Margins · derived
Gross margin77.8%−0.2 pt vs Q1 2017
Operating margin7.2%+1.5 pt vs Q1 2017
Net margin4.8%+7.4 pt vs Q1 2017

What the release said

No earnings release is on file for this quarter. Its figures came with the 10-Q.

Same quarter

MetricQ1 2018Q1 2017Q1 2016Q1 2015
Revenue$108.71M$102.74M$98.68M$89.76M
Net Income$5.23M-$2.65M$3.84M-$8.38M
EPS Diluted$0.27-$0.15$0.20-$0.45

The same fiscal quarter, prior years. Thaler holds no estimates to compare against.

Orthofix Medical Inc. · CIK 884624 · Engraved from SEC EDGAR